2011
DOI: 10.1007/978-3-642-16499-6_19
|View full text |Cite
|
Sign up to set email alerts
|

Neuropeptides in Lower Urinary Tract Function

Abstract: Numerous neuropeptide/receptor systems including vasoactive intestinal polypeptide, pituitary adenylate cyclase-activating polypeptide, calcitonin gene-related peptide, substance P, neurokinin A, bradykinin, and endothelin-1 are expressed in the lower urinary tract (LUT) in both neural and non-neural (e.g., urothelium) components. LUT neuropeptide immunoreactivity is present in afferent and autonomic efferent neurons innervating the bladder and urethra and in the urothelium of the urinary bladder. Neuropeptide… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
63
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 68 publications
(70 citation statements)
references
References 149 publications
(262 reference statements)
2
63
0
Order By: Relevance
“…On the other hand, the significantly lower PACAP38 immunoreactivity in the tumor might be caused by the degeneration of the structures containing high amount of PACAP such as nerve fibers and cells of the tubular system. PACAP and its receptors are also present in the lower urinary tract such as ureter, urinary bladder, and urethra (Arms and Vizzard 2011). Higher PACAP38-LI was measured by RIA in extracts of rat ureter, urinary bladder, and urethra compared to PACAP27-LI (Fahrenkrug and Hannibal 1998).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…On the other hand, the significantly lower PACAP38 immunoreactivity in the tumor might be caused by the degeneration of the structures containing high amount of PACAP such as nerve fibers and cells of the tubular system. PACAP and its receptors are also present in the lower urinary tract such as ureter, urinary bladder, and urethra (Arms and Vizzard 2011). Higher PACAP38-LI was measured by RIA in extracts of rat ureter, urinary bladder, and urethra compared to PACAP27-LI (Fahrenkrug and Hannibal 1998).…”
Section: Discussionmentioning
confidence: 99%
“…PACAP27 and PACAP38 immunoreactivities and PACAP receptors have also been detected in the urinary tract of different species (pig, duck, fish, rats, mouse) (Moller et al 1993;Olsson and Holmgren 1994;Ishizuka et al 1995;Mirabella et al 2001;Bossowska et al 2009;Szakaly et al 2010;Arms and Vizzard 2011;Brubel et al 2011). Higher level of PACAP38 immunoreactivity was measured in the ureter, urinary bladder, urethra, and kidney samples compared to PACAP27 in rats (Fahrenkrug and Hannibal 1998).…”
Section: Introductionmentioning
confidence: 97%
See 1 more Smart Citation
“…Immunohistochemical studies of the bladder have identified the presence of a number of neuropeptides including tachykinins, enkephalin, calcitonin gene related peptide (CGRP), vasoactive intestinal peptide (VIP) and neuropeptide Y (Arms & Vizzard, 2011). Some of these have been associated with efferent nerves, while others are found in the afferent nerves within the lamina propria.…”
Section: Discussionmentioning
confidence: 99%
“…These particular markers were selected based on their presence in the NG (Lewis et al, 1995, Michael and Priestley, 1999, Hubscher et al, 2001, Wang et al, 2014, involvement in the spinal and vagal circuitry (Bradbury et al, 1998, Cockayne et al, 2000, Vizzard, 2001, Young et al, 2008, Zhong et al, 2008, Banerjee et al, 2009a, McIlwrath et al, 2009) and the potential physiological role these markers may play in nociceptive signaling (Burnstock, 1996, Cook et al, 1997. In addition, anatomical evidence that the vagus nerve provides sensory innervation to the bladder in male rats and the presence of these cellular markers in bladder tissue (Liu et al, 2009, Birder, 2010, Arms and Vizzard, 2011, Birder, 2011, Birder et al, 2012, Birder and Andersson, 2013 …”
Section: Clinical Relevancementioning
confidence: 99%